These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8741797)

  • 1. Viruses and human cancers: challenges for preventive strategies.
    de The G
    Environ Health Perspect; 1995 Nov; 103 Suppl 8(Suppl 8):269-73. PubMed ID: 8741797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus and cancers of the head and neck.
    Goldenberg D; Golz A; Netzer A; Rosenblatt E; Rachmiel A; Goldenberg RF; Joachims HZ
    Am J Otolaryngol; 2001; 22(3):197-205. PubMed ID: 11351290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma.
    Shah KM; Young LS
    Clin Microbiol Infect; 2009 Nov; 15(11):982-8. PubMed ID: 19874382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview: viral agents and cancer.
    Mueller N
    Environ Health Perspect; 1995 Nov; 103 Suppl 8(Suppl 8):259-61. PubMed ID: 8741795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
    Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
    Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-associated lymphomas, leukaemias and immunodeficiencies in Africa.
    de-Thé G
    IARC Sci Publ; 1984; (63):727-44. PubMed ID: 6100286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus.
    Pearson G; Dewey F; Klein G; Henle G; Henle W
    J Natl Cancer Inst; 1970 Nov; 45(5):989-95. PubMed ID: 18605425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of the inflammatory response mechanisms mediated by natural and induced regulatory T-cells in HCV-, HTLV-1-, and EBV-associated cancers.
    Ouaguia L; Mrizak D; Renaud S; Moralès O; Delhem N
    Mediators Inflamm; 2014; 2014():564296. PubMed ID: 25525301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic role of Epstein-Barr virus in human cancer.
    Takada K; Shimizu N; Tanabe-Tochikura A; Kuroiwa Y
    Intervirology; 1995; 38(3-4):214-20. PubMed ID: 8682619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus and oncogenesis: from latent genes to tumours.
    Young LS; Murray PG
    Oncogene; 2003 Aug; 22(33):5108-21. PubMed ID: 12910248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of Virus Infection and Human Cancer.
    Chen CJ; You SL; Hsu WL; Yang HI; Lee MH; Chen HC; Chen YY; Liu J; Hu HH; Lin YJ; Chu YJ; Huang YT; Chiang CJ; Chien YC
    Recent Results Cancer Res; 2021; 217():13-45. PubMed ID: 33200360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious agents and cancer: criteria for a causal relation.
    Pagano JS; Blaser M; Buendia MA; Damania B; Khalili K; Raab-Traub N; Roizman B
    Semin Cancer Biol; 2004 Dec; 14(6):453-71. PubMed ID: 15489139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral infections and human cancers: the legacy of Denis Burkitt.
    Harford JB
    Br J Haematol; 2012 Mar; 156(6):709-18. PubMed ID: 22233526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of virus infection and human cancer.
    Chen CJ; Hsu WL; Yang HI; Lee MH; Chen HC; Chien YC; You SL
    Recent Results Cancer Res; 2014; 193():11-32. PubMed ID: 24008291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious agents in human cancers: lessons in immunity and immunomodulation from gammaherpesviruses EBV and KSHV.
    Taylor GS; Blackbourn DJ
    Cancer Lett; 2011 Jun; 305(2):263-78. PubMed ID: 21470769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphotropic viruses, Epstein-Barr virus (EBV) and human T-cell lymphotropic virus-I (HTLV-I)/adult T-cell leukemia virus (ATLV), and HTLV-III/human immune deficiency virus (HIV) as etiological agents of malignant lymphoma and immune deficiency.
    Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S1-6. PubMed ID: 2881552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viruses and human cancer.
    Vousden KH; Farrell PJ
    Br Med Bull; 1994 Jul; 50(3):560-81. PubMed ID: 7987641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of a vaccine for the prevention of Epstein-Barr virus infection: ethical and logistic considerations.
    Epstein MA
    Cancer Res; 1976 Feb; 36(2 pt 2):711-4. PubMed ID: 175931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel hypotheses for the roles of EBNA-1 and BHRF1 in EBV-related cancers.
    Horner D; Lewis M; Farrell PJ
    Intervirology; 1995; 38(3-4):195-205. PubMed ID: 8682617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus: 40 years on.
    Young LS; Rickinson AB
    Nat Rev Cancer; 2004 Oct; 4(10):757-68. PubMed ID: 15510157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.